Anrikefon
Small moleculeexperimental
Clinical trial activity
18 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
5
Phase 2
9
Phase 3
4
Phase 4
3
Earliest trial started Oct 31, 2019 (NCT04110886)
Timeline
Indications
Studied for
- Analgesia · Phase 2
- Analgesics · Phase 1
- Chronic Kidney Disease-Mineral and Bone Disorder · Phase 1
- Chronic Pain · Phase 1
- Healthy Volunteers · Phase 1
- Kidney Failure, Chronic · Phase 1
- Laparoscopy · Phase 4
- Pain · Phase 4
- Postoperative Complications · Phase 3
- Postoperative Nausea and Vomiting · Phase 4
- Postoperative Pain · Phase 1
- Pruritus · Phase 3
Mechanism of action
- Kappa opioid receptorAGONIST
OPRK1 agonist
Chemistry & pharmacology
Loading structure…
SMILES
CC(=O)N1CC2(CCN(C(=O)[C@@H](CCCCN)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](Cc3ccccc3)NC(=O)[C@H](N)Cc3ccccc3)CC2)C1- Mol. weight
- 703.93 g/mol
- Lipinski Ro5
- 1 violation(s)
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL5095089 ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07269106 | Phase 4 | Dec 1, 2025 | — |
| NCT07246785 | Phase 4 | Nov 30, 2025 | Peking University |
| NCT07186426 | Phase 3 | Jul 28, 2025 | Haisco Pharmaceutical |
| NCT06290375 | Phase 2 | Mar 8, 2024 | Haisco Pharmaceutical |
| NCT06359535 | Phase 4 | Feb 23, 2024 | Sichuan University |
| NCT06170476 | N/A | Nov 10, 2023 | Sichuan University |
| NCT06238388 | Phase 1 | Oct 10, 2023 | Haisco Pharmaceutical |
| NCT05947097 | Phase 1 | Apr 24, 2023 | Haisco Pharmaceutical, Shandong Province Qianfoshan Hospital |
| NCT05390905 | Phase 3 | May 31, 2022 | Haisco Pharmaceutical |
| NCT05135390 | Phase 3 | Dec 31, 2021 | Haisco Pharmaceutical |
| NCT04999787 | Phase 2 | Sep 30, 2021 | Haisco Pharmaceutical |
| NCT05835934 | Phase 1 | Jun 15, 2021 | Haisco Pharmaceutical, Soochow University |
| NCT04738357 | Phase 3 | Mar 20, 2021 | Haisco Pharmaceutical |
| NCT04470154 | Phase 2 | Sep 15, 2020 | Haisco Pharmaceutical |
| NCT04424251 | Phase 2 | Sep 1, 2020 | Haisco Pharmaceutical |
| NCT04470128 | Phase 2 | Aug 31, 2020 | Haisco Pharmaceutical |
| NCT04213196 | Phase 1 | Dec 30, 2019 | Haisco Pharmaceutical, Zhejiang University |
| NCT04110886 | Phase 1 | Oct 31, 2019 | Haisco Pharmaceutical |
Showing 18 of 18 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Haisco Pharmaceutical | For profit | 14 | 14 | 3 | 2019 |
| Sichuan University | Academic/Hospital | 2 | 2 | 2 | 2023 |
| Peking University | Academic/Hospital | 1 | 1 | 1 | 2025 |
| Shandong Province Qianfoshan Hospital | Academic/Hospital | 1 | 0 | 1 | 2023 |
| Soochow University | Academic/Hospital | 1 | 0 | 1 | 2021 |
| Zhejiang University | Academic/Hospital | 1 | 0 | 1 | 2019 |
6 organizations
Page 1 / 1